Showing 1 - 20 results of 21 for search '"James P. Allison"', query time: 0.39s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    Immunological targets for cancer therapy: new recognition by Shurin MR

    Published 2018-11-01
    “…Blocking cancer progression by eliminating brakes on immune effector cells in the tumor environment has jointly earned James P Allison, PhD (Department of Immunology, MD Anderson Cancer Center, University of Texas, Houston, TX, USA) and Tasuku Honjo, MD, PhD (Graduate School of Medicine, Kyoto University, Kyoto, Japan) the Nobel Prize in Physiology or Medicine in 2018. …”
    Get full text
    Article
  18. 18

    Immune checkpoint blockade therapy: The 2014 Tang prize in biopharmaceutical science by Ya-Shan Chen, Chia-Rui Shen

    Published 2015-02-01
    “…The first Tang Prize for Biopharmaceutical Science has been awarded to Prof. James P. Allison and Prof. Tasuku Honjo for their contributions leading to an entirely new way to treat cancer by blocking the molecules cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and programmed cell death protein 1 (PD-1) that turn off immune response. …”
    Get full text
    Article
  19. 19

    Systems glycobiology for discovering drug targets, biomarkers, and rational designs for glyco-immunotherapy by Austin W. T. Chiang, Hratch M. Baghdassarian, Benjamin P. Kellman, Bokan Bao, James T. Sorrentino, Chenguang Liang, Chih-Chung Kuo, Helen O. Masson, Nathan E. Lewis

    Published 2021-06-01
    “…In 2018, two pioneer immunotherapy innovators, Tasuku Honjo and James P. Allison, were awarded the Nobel Prize for their landmark cancer immunotherapy work regarding “cancer therapy by inhibition of negative immune regulation” –CTLA4 and PD-1 immune checkpoints. …”
    Get full text
    Article
  20. 20

    Top 100 Most Cited Publications on CTLA-4 Molecule in Cancer Research: A Bibliometric Analysis by Hossam El Idrissi, Ibtissam Balar

    Published 2023-01-01
    “…There were 1192 authors and the author with the highest number of papers was the Nobel Prize winner, Professor James P. Allison (17 papers; 8700 citations). CTLA-4 blockade was the most frequent keyword (42.1%), followed by metastatic melanoma (4.26%). …”
    Get full text
    Article